Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Current Taxes (2018 - 2023)

Historic Current Taxes for BioNexus Gene Lab (BGLC) over the last 6 years, with Q3 2023 value amounting to $2177.0.

  • BioNexus Gene Lab's Current Taxes changed N/A to $2177.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $2177.0, marking a year-over-year change of. This contributed to the annual value of $97585.0 for FY2021, which is 5915.87% up from last year.
  • As of Q3 2023, BioNexus Gene Lab's Current Taxes stood at $2177.0.
  • BioNexus Gene Lab's Current Taxes' 5-year high stood at $148199.0 during Q3 2021, with a 5-year trough of $174.0 in Q2 2020.
  • In the last 5 years, BioNexus Gene Lab's Current Taxes had a median value of $37221.0 in 2019 and averaged $50237.4.
  • In the last 5 years, BioNexus Gene Lab's Current Taxes plummeted by 6637.54% in 2020 and then skyrocketed by 6091206.9% in 2021.
  • Over the past 5 years, BioNexus Gene Lab's Current Taxes (Quarter) stood at $34338.0 in 2019, then soared by 78.56% to $61313.0 in 2020, then surged by 59.16% to $97585.0 in 2021, then crashed by 58.9% to $40104.0 in 2022, then plummeted by 94.57% to $2177.0 in 2023.
  • Its last three reported values are $2177.0 in Q3 2023, $40104.0 for Q2 2022, and $71705.0 during Q1 2022.